نتائج البحث

Survey on adverse events associated with drug therapy for breast cancer patients.

• Authors : Hara F; The Cancer Institute Hospital Of JFCR, 3-8-31 Ariake, Koto-ku, Tokyo, Japan. .; Nagasaki R

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

• Source: BMC women's health [BMC Womens Health] 2024 Oct 03; Vol. 24 (1), pp. 545. Date of Electronic Publication: 2024 Oct 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Novel drug therapy of acute hepatic failure induced in rats by a combination of tadalafil and Lepidium sativum.

• Authors : Sabra, Mahmoud S.¹ (AUTHOR) ; Mohammed, Ahmed A.² (AUTHOR); Hassanein, Khaled M. Ahmed³ (AUTHOR)

Subjects: *DRUG efficacy; *ALKALINE phosphatase; *GAMMA-glutamyltransferase

• Source: BMC Complementary Medicine & Therapies. 2/27/2024, Vol. 24 Issue 1, p1-13. 13p.

تفاصيل العنوان

Model construction and drug therapy of primary ovarian insufficiency by ultrasound-guided injection.

• Authors : Dai, Fangfang¹ (AUTHOR); Liu, Hua¹ (AUTHOR); He, Juan² (AUTHOR)

• Source: Stem Cell Research & Therapy. 2/20/2024, Vol. 15 Issue 1, p1-19. 19p.

تفاصيل العنوان

A rare case of prostatic malakoplakia with multidrug-resistant Escherichia coli: a case report.

• Authors : Yang Q; Department of Infectious Diseases, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, 12 Changjia Lane, Jingzhong Street, Fucheng District, Mianyang, Sichuan, China. .; Chen X

Subjects: Drug Resistance, Multiple, Bacterial* ; Escherichia coli*/Escherichia coli*/Escherichia coli*/genetics ; Escherichia coli*/Escherichia coli*/Escherichia coli*/drug effects

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Oct 31; Vol. 24 (1), pp. 1226. Date of Electronic Publication: 2024 Oct 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Adult-onset Still's disease masquerading as acute coronary syndrome: a case report and review of the literature.

• Authors : Milne I; Penn State College of Medicine, Hershey, PA, USA.; Kanwar R

Subjects: Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/diagnosis ; Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/drug therapy ; Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/Still's Disease, Adult-Onset*/complications

• Source: Journal of medical case reports [J Med Case Rep] 2024 Oct 10; Vol. 18 (1), pp. 489. Date of Electronic Publication: 2024 Oct 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Association of first-line combination antiretroviral therapy with malaria among adult HIV-infected persons in Jos, Nigeria: a pilot cross sectional study.

• Authors : Onukak A; Infectious Diseases Unit, Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria. .; Infectious Diseases Unit, Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria. .

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/complications ; HIV Infections*/HIV Infections*/HIV Infections*/epidemiology

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Sep 27; Vol. 24 (1), pp. 1038. Date of Electronic Publication: 2024 Sep 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.

• Authors : Krugliak Cleveland N; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA. .; Ghosh S

Subjects: Adalimumab*/Adalimumab*/Adalimumab*/therapeutic use ; Adalimumab*/Adalimumab*/Adalimumab*/adverse effects ; Infliximab*/Infliximab*/Infliximab*/therapeutic use

• Source: BMC gastroenterology [BMC Gastroenterol] 2024 Sep 17; Vol. 24 (1), pp. 314. Date of Electronic Publication: 2024 Sep 17.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives.

• Authors : Sawami K; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

• Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Nov 15; Vol. 23 (1), pp. 410. Date of Electronic Publication: 2024 Nov 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Effects of melatonin supplementation on metabolic parameters, oxidative stress, and inflammatory biomarkers in diabetic patients with chronic kidney disease: study protocol for a double-blind, randomized controlled trial.

• Authors : Sadeghi S; Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.; Hakemi MS

Subjects: Melatonin*/Melatonin*/Melatonin*/administration & dosage ; Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy

• Source: Trials [Trials] 2024 Nov 13; Vol. 25 (1), pp. 757. Date of Electronic Publication: 2024 Nov 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.

• Authors : Ghosh S; Department of Microbiology and Immunology, Center for Microbiomics, Inflammation and Pathogenicity, UofL-Brown Cancer Center, University of Louisville, Louisville, KY, USA.; Singh R

Subjects: Colitis*/Colitis*/Colitis*/drug therapy ; Colitis*/Colitis*/Colitis*/chemically induced ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Nov 13; Vol. 22 (1), pp. 701. Date of Electronic Publication: 2024 Nov 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium:

تفاصيل العنوان